Fauré & Duruflé: Requiem

Maison symphonique February 13, 2022

This event has ended

See upcoming Classical events

Ensemble Vocal Arts-Québec and organist Jonathan Oldengarm evoke the divine afterworld with powerful performances of the Faure and Durufle Requiems. Fauré’s Requiem offers a radiant vision of heaven, comforting audiences far beyond the composer’s original Parisian congregation. Duruflé’s unique work is equally recognized as a masterpiece, being performed regularly since the composer's death. Experience these two Requiems in all their glory, in a beautiful rendition led by guest conductor Francis Choinière!

Fauré, Requiem Op. 48
Duruflé, Requiem  Op. 9


  • Venue : Maison symphonique
  • Producer / Presenter : Productions GFN
  • Choir : Ensemble vocal Arts-Québec | Organist : Jonathan Oldengarm | Mezzo-soprano : Marie-Andrée Mathieu | Baritone : Dominique Côté | Conductor : Francis Choinière
  • Duration : 1h35 including intermission
  • Photo credit : Tam Photography
  • The Grand Orgue Pierre-Béique was generously offered to the OSM by : Mrs. Jacqueline Desmarais
Masks must be worn at all times

Vaccine passport required
Masks must be worn at all times

Vaccine passport required

Please note that physical distancing protocols are in effect for this performance, which means that 1 seat will remain empty on each side of seated spectators, except for spectators from the same family bubble.

To attend the performance, ticketholders must comply with the usual health and safety measures, in addition to meeting the following two criteria:

  • All spectators aged 13 and up must show a vaccine passport, along with a proof of ID, at the entrance to the performance hall. A photo ID is required for people of ages 16 to 74.

  • All spectators aged 10 and up must wear a face covering at all times: when circulating and during the performance (masks are also strongly recommended for children of ages 2 to 9).

For more information on the health and safety measures in effect at Place des Arts or to read our FAQ, please see the COVID-19 page.

Go to top